Repligen (RGEN) Other Non-Current Assets (2011 - 2026)
Repligen's (RGEN) quarterly Other Non-Current Assets came in at $5.9 million in Q1 2026, up 178.42% year-on-year from $2.1 million in Q1 2025, and up 19.74% on a QoQ basis from $4.9 million in Q4 2025.
Repligen (RGEN) Other Non-Current Assets (2011 - 2026) Analysis & Trends
Repligen (RGEN) has 16 years of Other Non-Current Assets data on file, last reported at $5.9 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 178.42% year-over-year to $5.9 million in Q1 2026; TTM through Mar 2026 was $5.9 million, a 178.42% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 466.01% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $5.9 million, up from $4.9 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for RGEN reached as high as $5.9 million in Q1 2026 and fell as low as $631000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $1.9 million across 5 years, with a median of $1.2 million in 2023.
- Across the five-year window, Other Non-Current Assets plunged 48.2% in 2024 and jumped 582.49% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $815000.0 in 2022, then surged by 56.69% to $1.3 million in 2023, then tumbled by 32.03% to $868000.0 in 2024, then surged by 466.01% to $4.9 million in 2025, then rose by 19.74% to $5.9 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $5.9 million in Q1 2026, $4.9 million in Q4 2025, and $5.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | 5.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.88 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 5.11 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 868,000.00 |
| Sep 30, 2024 | 748,000.00 |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 956,000.00 |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.44 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | 815,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 769,000.00 |
| Mar 31, 2022 | 631,000.00 |
| Dec 31, 2021 | 615,000.00 |
| Sep 30, 2021 | 620,000.00 |
| Jun 30, 2021 | 610,000.00 |